Authored By: Sarah
10 Feb 2023

Vaccines Market Share, Segments, Trends, Growth, and Geography- Analysis, and Forecast 2022-2026

The vaccine market share is forecast to reach USD 28.28 billion, after growing at a CAGR of 4.13% during 2021-2026. The increased funding for vaccine development and new vaccine launches is analyzed to boost the vaccine market growth. Moreover, the development of nanoparticle vaccines is the major trend enhancing the overall market demand for vaccines during the forecast period.   

Get a snapshot of the vaccines market analysis: Unlock the Sample Report 

Browse Technavio's 136-page report and in-depth TOC on "Vaccines Market by Type (Prophylactic vaccines and Therapeutic vaccines) and Geography (North America, Europe, Asia, and Rest of World (ROW)).

View detailed Table of Contents Here:

Vaccines Market Share, Segments, Trends, Growth, and Geography- Analysis, and Forecast 2022-2026


  • Prophylactic vaccines: The vaccine market share growth in the prophylactic vaccines segment will be significant during the forecast period.

  • Therapeutic vaccines


  • North America: 48% of the market's growth will originate from North America. The increasing number of immunization programs and strong prevalence of infectious diseases such as influenza, hepatitis A, hepatitis B, HIV, measles, malaria, and tuberculosis, and non-infectious diseases such as cancer will facilitate the vaccines market growth in North America.

  • Europe 

  • Asia 

  • Rest of World (ROW) 

Key Takeaways: 

  • The vaccines market size will witness a YOY Growth Rate of 4.0% in 2022.  

  • The high cost of vaccine research, development, and manufacturing will be a major challenge for the vaccine market during the forecast period. 

  • Major key vaccines market players include: Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Novavax Inc., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE  

  • The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as North America, Europe, Asia, and Rest of World (ROW). 

Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth. 

Key data covered in the Vaccines Market report 

  • Precise market size estimation during the forecast period 2022-2026.  

  • CAGR of the vaccines market forecast during 2022-2026.  

  • Market-level data on units, average selling prices, and values of the vaccines market share.  

  • Prediction of the upcoming trends, drivers, and factors that challenge the growth of the vaccines market.  

  • Vaccines industry growth across North America, Europe, Asia, and Rest of World (ROW).

Read News Read Less
Interested in this report?
Get your sample now!